Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India

Approved by the US Food and Drug Administration, semaglutide medications mimic the body’s glucagon-like peptide 1 (GLP-1) hormone to help with insulin production and signal the brain to reduce appetite.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/0PFpdfg
via